跳至主要内容
临床试验/NCT05241912
NCT05241912Unknown早期 1 期

Supernormal Oxygen Delivery for Patients With Severe Burns:A Randomized Controlled Trial

Guangzhou Red Cross Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年2月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
发起方
入组人数
100
试验地点
1
主要终点
Complication

研究概览

简要总结

This is a randomized double-blinded study to investigate in which the groups are designated as the control group and the goal-directed fluid therapy group to further evaluate significant differences in rate of complications during burn surgery.

详细描述

This is a randomized double-blinded study to investigate the effect of control group and the goal-directed fluid therapy group on complications during surgery of the burn patients. The groups are designated as the control group and the oal-directed fluid therapy group to further evaluate significant differences in complications during the surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Severe burn patients

排除标准

  • Patients or families refuse to sign consent

研究组 & 干预措施

Goal-directed fluid group

Experimental

Intervention: administration of dobutamine 0.01 - 0.04 U/min after induction of anesthesia.

Intraoperative fluid management: administration of 2-4 ml/kg/hr of crystalloid solution.

干预措施: Dobutamine (Drug)

结局指标

主要结局

Complication

时间窗: One week after operation

perioperative complications

次要结局

未报告次要终点

研究者

发起方
Guangzhou Red Cross Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Liang Bing

Associate senior doctor

Guangzhou Red Cross Hospital

研究点 (1)

Loading locations...

相似试验